Abstract
Clinical signs and features include:
Also known as Osler-Weber-Rendu disease
Eighty percent present as spontaneous epistaxis
Arteriovenous malformations (AVMs) occur throughout the body including the gastrointestinal (GI) tract, lungs, liver, brain/spinal cord
Cutaneous lesions start to appear in adulthood and increase with age
Lesions appear as small macular telangiectasia that are 1–2 mm in diameter and blanch
Telangiectasia commonly occur on lips, tongue, palate, face (sun-exposed areas), nares, ears, conjunctiva, chest, hands, and feet
Fingertips can develop painful ulcers from the telangiectasia
Pathogenesis of this disease involves:
Autosomal dominant mutations: hereditary hemorrhagic telangiectasia (HHT)1, mutation in ENG on chromosome 9; HHT2, mutation in ACRVL1/ALK1 on chromosome 12; HHT3, mutation on chromosome 5q; HHT4, mutation on chromosome 7p; HHT with juvenile polyposis, mutation of SMAD4; HHT2 with primary pulmonary hypertension, mutation of BMPRII on chromosome 2
Access provided by Autonomous University of Puebla. Download chapter PDF
Similar content being viewed by others
Keywords
- Pulmonary Hypertension
- Arteriovenous Malformation
- Yttrium Aluminum Garnet
- Cutaneous Lesion
- Hereditary Hemorrhagic Telangiectasia
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
Clinical signs and features include:
-
Also known as Osler-Weber-Rendu disease
-
Eighty percent present as spontaneous epistaxis [1]
-
Arteriovenous malformations (AVMs) occur throughout the body including the gastrointestinal (GI) tract, lungs, liver, brain/spinal cord
-
Cutaneous lesions start to appear in adulthood and increase with age [1]
-
Lesions appear as small macular telangiectasia that are 1–2 mm in diameter and blanch [1]
-
Telangiectasia commonly occur on lips, tongue, palate, face (sun-exposed areas), nares, ears, conjunctiva, chest, hands, and feet (see Fig. 34.1) [1]
-
Fingertips can develop painful ulcers from the telangiectasia
Pathogenesis of this disease involves:
-
Autosomal dominant mutations: hereditary hemorrhagic telangiectasia (HHT)1, mutation in ENG on chromosome 9; HHT2, mutation in ACRVL1/ALK1 on chromosome 12; HHT3, mutation on chromosome 5q; HHT4, mutation on chromosome 7p; HHT with juvenile polyposis, mutation of SMAD4; HHT2 with primary pulmonary hypertension, mutation of BMPRII on chromosome 2 [2, 3]
-
Mutations lead to aberrant response to transforming growth factor beta (TGF-β) family signals for angiogenesis
-
Ultimately signal errors cause blood vessels to mature inappropriately
Histopathological features include:
-
Initially see dilatation post-capillary venules
-
Ultimately dilated post-capillary venules enlarge and connect with arterioles eliminating capillary bed
-
Vessels are often thin walled and surrounded by fibrosis
-
A perivascular lymphocytic infiltrate may also be noted around involved vessels
The diagnosis is made using a combination of:
-
Curaçao criteria: (1) epistaxis; (2) telangiectasias at characteristic sites; (3) visceral AVMs in GI tract/liver/lungs/brain/spinal cord; (4) family history: de novo mutation is rare and the disease has a nearly 100% penetrance by age 40 [4]
-
If ≤3 of above, HHT can be diagnosed; if ≤2, HHT is suspected; if only 1, HHT is unlikely
-
In children with a parent who has HHT, cannot rule out HHT until genetic tests confirm no mutation [2]
-
Genetic testing reveals mutation in 80–90% of cases
The differential diagnosis should include:
-
Von Willebrand disease
Treatment options include [4]:
-
Mostly cosmetic for cutaneous lesions
-
Long-pulsed Nd: YAG (neodymium-doped yttrium aluminum garnet) laser is effective
-
Skin grafts effective for painful ulcerations on fingertips
References
Ward SK, Roenigk HH, Gordon KB. Dermatological manifestations of gastroenterological disorders. Gastroenterol Clin N Am. 1998;27:615–36.
Sharathkumar AA, Shapiro A. Hereditary haemorrhagic telangiectasia. Haemophilia. 2008;14:1269–80.
Shlovin CL. Hereditary haemorrhagic telangiectasia: pathophysiology, diagnosis, and treatment. Blood Rev. 2010;24:203–19.
Dupis-Girod S, Bailly S, Plauchu H. Hereditary hemorrhagic telangiectasia: from molecular biology to patient care. J Thromb Haemost. 2010;8:1447–56.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer Science+Business Media New York
About this chapter
Cite this chapter
Zakko, L., Finch, J., Rothe, M.J., Grant-Kels, J.M. (2013). Hereditary Hemorrhagic Telangiectasia: Dermatological Features. In: Wu, G., Selsky, N., Grant-Kels, J. (eds) Atlas of Dermatological Manifestations of Gastrointestinal Disease. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-6191-3_34
Download citation
DOI: https://doi.org/10.1007/978-1-4614-6191-3_34
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4614-6190-6
Online ISBN: 978-1-4614-6191-3
eBook Packages: MedicineMedicine (R0)